logo
logo

NanoSyrinx raised £10M in a funding round co-led by BGF, Octopus Ventures, and M Ventures to advance its nano syringe delivery platform for biologic therapeutics.

NanoSyrinx raised £10M in a funding round co-led by BGF, Octopus Ventures, and M Ventures to advance its nano syringe delivery platform for biologic therapeutics.

09/10/24, 11:14 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/GB.svgwarwick university
Money raised
£10 million
Industry
information technology
Investors
Eli Lilly And Company, Meltwind, Iq Capital, M Ventures, Octopus Ventures, Bgf
NanoSyrinx has successfully closed a £10 million financing round to enhance its technology platform focused on intracellular delivery of biologic therapeutics. This funding aims to support the development of therapeutics targeting 'undruggable' intracellular targets.

Company Info

Company
NanoSyrinx
Location
warwick university, england, united kingdom
Additional Info
NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.

Related People